Lowell L. Hart, MD, FACP
- Associate Professor, Hematology and Oncology
Lowell L. Hart, MD, FACP
Research Interests
- Phase 1 Clinical Trials
- Lung Cancer
- Breast Cancer
- Education
- MD, State University of New York at Syracuse, 1980
- Residency
- Internal Medicine, University of Miami School of Medicine, 1983
- Fellowship
- Pediatric Hematology and Oncology, Duke University Medical Center, 1986
- Board Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
- Positions
- Associate Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Paluch-Shimon S, Campone M, Blackwell KL, André F, Winer EP, Janni W, Verma S, Conte P, Arteaga CL, Cameron DA, Petrakova K, Hart LL, Villanueva C, Chan A, Jakobsen E, Nusch A, Burdaeva O, Grischke EM, Alba E, Wist E, Marschner N, Favret AM, Yardley D, Bachelot T, Tseng LM, Blau S, Xuan F, Souami F, Miller M, Germa C, Hirawat S, O'Shaughnessy J. N. Engl. J. Med. 2016 11; 375(18):1738-1748.
- A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy. Eng C, Bessudo A, Hart LL, Severtsev A, Gladkov O, Müller L, Kopp MV, Vladimirov V, Langdon R, Kotiv B, Barni S, Hsu C, Bolotin E, von Roemeling R, Schwartz B, Bendell JC. Int. J. Cancer. 2016 Jul; 139(1):177-86.
- Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors. Von Hoff DD, Mita MM, Ramanathan RK, Weiss GJ, Mita AC, LoRusso PM, Burris HA, Hart LL, Low SC, Parsons DM, Zale SE, Summa JM, Youssoufian H, Sachdev JC. Clin. Cancer Res. 2016 07; 22(13):3157-63.
- Effects of Lifetime Occupational Pesticide Exposure on Postural Control Among Farmworkers and Non-Farmworkers. Sunwook K, Nussbaum MA, Quandt SA, Laurienti PJ, Arcury TA. J. Occup. Environ. Med. 2016 Feb; 58(2):133-9.
- A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors. Bendell JC, Jones SF, Hart L, Pant S, Moyhuddin A, Lane CM, Earwood C, Murphy P, Patton J, Penley WC, Thompson D, Infante JR. Cancer Invest. 2015; 33(10):477-82.